HallR.R., NewlingD.W.W., RamsdenP.D., RichardsB., RobinsonM.R.G., SmithP.H.: Treatment of invasive bladder cancer by local resection and high dose Methotrexate. Brit. J. Urol., 56; 668–672 (1984).
2.
HallR.R.: Trans-urethral resection and systemic chemotherapy as primary treatment for T3 bladder cancer. In: Bladder Cancer: Future Directions For Treatment. Advanced in Cancer Chemotherapy, Feb. 27-March 2, 1986.
3.
HerrH.W.: Conservative management of muscle-infiltrating bladder cancer: prospective experience. J. Urol., 138; 1162 (1987).
4.
FetterT.H., BogaevJ.H., McCuskeyB., SeresJ.L.: Carcinoma of the bladder: sites of metastases. J. Urol., 81; 746–748 (1959).
5.
SocquetY.: Combined surgery and adjuvant chemotherapy with high dose Methotrexate and folinic acid rescue (MDMTX-CF) for infiltrating tumors of the bladder. Brit. J. Urol., 53; 439–443 (1981).
6.
SocquetY.: Personal communication (1984).
7.
SkinnerD.G., TiftJ.P., KaufmanJ.J.: High dose, short course pre-operative radiation therapy and immediate single stage radical cystectomy with pelvic lymph node dissection in the management of bladder cancer. J. Urol., 127; 671–674 (1982).
8.
SmithJ.A., WhitmoreW.F.: Regional lymph node metastasis from bladder cancer. J. Urol., 126; 591–593 (1981).
9.
SternbergC.N., YagodaA., WhitmoreW.F.Jr.: M-VAC (methotrexate, vinblastina, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139; 461 (1988).
TenagliaR., RossettiR., AccorsiP., RizzoM., Di SilverioF.: Strategia terapeutica nei tumori infiltranti della vescica. Meeting-point sul trattamento chemiochirurgico: ulteriori dati sul nuovo staging proposto. I corso internaz. Urologia, Chieti 16 novembre 1988; Acta Medica Editrice.
12.
TenagliaR., RossettiR., AccorsiP., Di FedericoG. e Di SilverioF.: La chemioterapia sistemica nel carcinoma vescicale avanzato: nuova strategia terapeutica e nuova stadiazione. 16° Congr. Soc. Ital. Chemioterapia, Firenze 12–15 marzo 1989.
13.
YagodaA.: Chemotherapy for advanced bladder cancer. In: Bladder Cancer Future Directions For Treatment. Advances in Cancer Chemotherapy, Feb. 27 — March 2, 1986.